Stay updated on CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial

Sign up to get notified when there's something new on the CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Added MedlinePlus Genetics topic on schizophrenia to the page. No deletions were found.
    Difference
    0.1%
    Check dated 2025-10-12T14:41:10.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Major update to page status notice and version; removal of a genetics topic balanced by an explicit operating-status message and version bump.
    Difference
    3%
    Check dated 2025-10-05T10:23:27.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Updated topics: adding schizophrenia coverage under MedlinePlus and MedlinePlus Genetics; removing broader or separate drug safety categories; version updated from v3.0.2 to v3.1.0.
    Difference
    0.5%
    Check dated 2025-09-28T03:19:44.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Added results timing, detailed Emraclidine dose arms (10 mg and 30 mg), comprehensive PANSS/CGI endpoints, safety measures, and regulatory identifiers; removed some older measures and terminology.
    Difference
    49%
    Check dated 2025-09-20T22:18:20.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Page revision updated to v3.0.2, replacing v3.0.1; and the 'Back to Top' element was removed.
    Difference
    0.2%
    Check dated 2025-09-13T17:49:38.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.
    Difference
    0.2%
    Check dated 2025-09-06T17:27:33.000Z thumbnail image

Stay in the know with updates to CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial page.